Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses

Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses Francesco Bedogni, Maria Luisa Laudisa, Samuele Pizzocri, Corrado Tamburino, Gian Paolo Ussia, Anna Sonia Petronio, Massimo Napodano, Angelo Ramondo, Patrizia Presbitero, Federica Etto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Cardiovascular interventions 2011-11, Vol.4 (11), p.1228-1234
Hauptverfasser: Bedogni, Francesco, MD, Laudisa, Maria Luisa, MD, PhD, Pizzocri, Samuele, MD, Tamburino, Corrado, MD, Ussia, Gian Paolo, MD, Petronio, Anna Sonia, MD, Napodano, Massimo, MD, Ramondo, Angelo, MD, Presbitero, Patrizia, MD, Ettori, Federica, MD, Santoro, Gennaro, MD, Klugman, Silvio, MD, De Marco, Federico, MD, Brambilla, Nedy, MD, Testa, Luca, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1234
container_issue 11
container_start_page 1228
container_title JACC. Cardiovascular interventions
container_volume 4
creator Bedogni, Francesco, MD
Laudisa, Maria Luisa, MD, PhD
Pizzocri, Samuele, MD
Tamburino, Corrado, MD
Ussia, Gian Paolo, MD
Petronio, Anna Sonia, MD
Napodano, Massimo, MD
Ramondo, Angelo, MD
Presbitero, Patrizia, MD
Ettori, Federica, MD
Santoro, Gennaro, MD
Klugman, Silvio, MD
De Marco, Federico, MD
Brambilla, Nedy, MD
Testa, Luca, MD, PhD
description Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses Francesco Bedogni, Maria Luisa Laudisa, Samuele Pizzocri, Corrado Tamburino, Gian Paolo Ussia, Anna Sonia Petronio, Massimo Napodano, Angelo Ramondo, Patrizia Presbitero, Federica Ettori, Gennaro Santoro, Silvio Klugman, Federico De Marco, Nedy Brambilla, Luca Testa CoreValve Revalving System (Medtronic, Minneapolis, Minnesota) implantation could be a valid option for patients with a failed aortic bioprosthesis deemed at prohibitive risk for surgical redo. In this multicenter consecutive cohort of 25 patients, the CoreValve Revalving System was feasible and effective regardless of the prevalent cause of failure (regurgitation or stenosis), with excellent procedural success and a considerable 6-month survival rate. These results can significantly affect the treatment of such a high-risk population.
doi_str_mv 10.1016/j.jcin.2011.10.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_906154534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1936879811007229</els_id><sourcerecordid>906154534</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4352-4c1fe9e2e959b71696be093b2f4ad805a1dcbb91480c05c162da60892d9a64fd3</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi0EoqXwAhyQb5yyjJ3EiSWE1K4oVKqExLZcLceeFIfEXuxkpX17HLZw4MBpRuP_n_F8Q8hrBhsGTLwbNoNxfsOBsVzYAPAn5Jy1jSgaAfXTnMtSFG0j2zPyIqUBQIBs-HNyxjljtRDVOUl3Uftk9PwdZ4z0mx4PWDhf_E7ozbQftZ_17IKn98n5B7oNEU-PX_GQ41rbHdOME-1DpNfajWjpbokPzuiRXoY4O0OvXNjHkPKUhOkledbrMeGrx3hB7q8_3m0_F7dfPt1sL28LU5U1LyrDepTIUdaya5iQokOQZcf7StsWas2s6TrJqhYM1IYJbrWAVnIrtah6W16Qt6e-efTPBdOsJpcMjnklDEtSEgSrq7qsspKflCZ_MkXs1T66ScejYqBW1mpQK2u1sl5rmXU2vXlsv3QT2r-WP3Cz4P1JgHnJg8OoknHoDVoX0czKBvf__h_-sZvR-ZXqDzxiGsISfcanmEpcgdqt116PzRhAw7ksfwE-L6ZR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>906154534</pqid></control><display><type>article</type><title>Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Bedogni, Francesco, MD ; Laudisa, Maria Luisa, MD, PhD ; Pizzocri, Samuele, MD ; Tamburino, Corrado, MD ; Ussia, Gian Paolo, MD ; Petronio, Anna Sonia, MD ; Napodano, Massimo, MD ; Ramondo, Angelo, MD ; Presbitero, Patrizia, MD ; Ettori, Federica, MD ; Santoro, Gennaro, MD ; Klugman, Silvio, MD ; De Marco, Federico, MD ; Brambilla, Nedy, MD ; Testa, Luca, MD, PhD</creator><creatorcontrib>Bedogni, Francesco, MD ; Laudisa, Maria Luisa, MD, PhD ; Pizzocri, Samuele, MD ; Tamburino, Corrado, MD ; Ussia, Gian Paolo, MD ; Petronio, Anna Sonia, MD ; Napodano, Massimo, MD ; Ramondo, Angelo, MD ; Presbitero, Patrizia, MD ; Ettori, Federica, MD ; Santoro, Gennaro, MD ; Klugman, Silvio, MD ; De Marco, Federico, MD ; Brambilla, Nedy, MD ; Testa, Luca, MD, PhD</creatorcontrib><description>Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses Francesco Bedogni, Maria Luisa Laudisa, Samuele Pizzocri, Corrado Tamburino, Gian Paolo Ussia, Anna Sonia Petronio, Massimo Napodano, Angelo Ramondo, Patrizia Presbitero, Federica Ettori, Gennaro Santoro, Silvio Klugman, Federico De Marco, Nedy Brambilla, Luca Testa CoreValve Revalving System (Medtronic, Minneapolis, Minnesota) implantation could be a valid option for patients with a failed aortic bioprosthesis deemed at prohibitive risk for surgical redo. In this multicenter consecutive cohort of 25 patients, the CoreValve Revalving System was feasible and effective regardless of the prevalent cause of failure (regurgitation or stenosis), with excellent procedural success and a considerable 6-month survival rate. These results can significantly affect the treatment of such a high-risk population.</description><identifier>ISSN: 1936-8798</identifier><identifier>EISSN: 1876-7605</identifier><identifier>DOI: 10.1016/j.jcin.2011.10.002</identifier><identifier>PMID: 22115664</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Aortic Valve Stenosis - diagnosis ; Aortic Valve Stenosis - physiopathology ; Aortic Valve Stenosis - surgery ; Bioprosthesis ; Cardiac Catheterization - adverse effects ; Cardiac Catheterization - instrumentation ; Cardiac Catheterization - mortality ; Cardiovascular ; CoreValve Revalving System ; failed surgical aortic bioprosthesis ; Feasibility Studies ; Female ; Heart Valve Prosthesis ; Heart Valve Prosthesis Implantation - adverse effects ; Heart Valve Prosthesis Implantation - instrumentation ; Heart Valve Prosthesis Implantation - methods ; Heart Valve Prosthesis Implantation - mortality ; Humans ; Italy ; Male ; Prosthesis Design ; Prosthesis Failure ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; TAVI ; Time Factors ; Treatment Outcome</subject><ispartof>JACC. Cardiovascular interventions, 2011-11, Vol.4 (11), p.1228-1234</ispartof><rights>American College of Cardiology Foundation</rights><rights>2011 American College of Cardiology Foundation</rights><rights>Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4352-4c1fe9e2e959b71696be093b2f4ad805a1dcbb91480c05c162da60892d9a64fd3</citedby><cites>FETCH-LOGICAL-c4352-4c1fe9e2e959b71696be093b2f4ad805a1dcbb91480c05c162da60892d9a64fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1936879811007229$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22115664$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bedogni, Francesco, MD</creatorcontrib><creatorcontrib>Laudisa, Maria Luisa, MD, PhD</creatorcontrib><creatorcontrib>Pizzocri, Samuele, MD</creatorcontrib><creatorcontrib>Tamburino, Corrado, MD</creatorcontrib><creatorcontrib>Ussia, Gian Paolo, MD</creatorcontrib><creatorcontrib>Petronio, Anna Sonia, MD</creatorcontrib><creatorcontrib>Napodano, Massimo, MD</creatorcontrib><creatorcontrib>Ramondo, Angelo, MD</creatorcontrib><creatorcontrib>Presbitero, Patrizia, MD</creatorcontrib><creatorcontrib>Ettori, Federica, MD</creatorcontrib><creatorcontrib>Santoro, Gennaro, MD</creatorcontrib><creatorcontrib>Klugman, Silvio, MD</creatorcontrib><creatorcontrib>De Marco, Federico, MD</creatorcontrib><creatorcontrib>Brambilla, Nedy, MD</creatorcontrib><creatorcontrib>Testa, Luca, MD, PhD</creatorcontrib><title>Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses</title><title>JACC. Cardiovascular interventions</title><addtitle>JACC Cardiovasc Interv</addtitle><description>Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses Francesco Bedogni, Maria Luisa Laudisa, Samuele Pizzocri, Corrado Tamburino, Gian Paolo Ussia, Anna Sonia Petronio, Massimo Napodano, Angelo Ramondo, Patrizia Presbitero, Federica Ettori, Gennaro Santoro, Silvio Klugman, Federico De Marco, Nedy Brambilla, Luca Testa CoreValve Revalving System (Medtronic, Minneapolis, Minnesota) implantation could be a valid option for patients with a failed aortic bioprosthesis deemed at prohibitive risk for surgical redo. In this multicenter consecutive cohort of 25 patients, the CoreValve Revalving System was feasible and effective regardless of the prevalent cause of failure (regurgitation or stenosis), with excellent procedural success and a considerable 6-month survival rate. These results can significantly affect the treatment of such a high-risk population.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aortic Valve Stenosis - diagnosis</subject><subject>Aortic Valve Stenosis - physiopathology</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Bioprosthesis</subject><subject>Cardiac Catheterization - adverse effects</subject><subject>Cardiac Catheterization - instrumentation</subject><subject>Cardiac Catheterization - mortality</subject><subject>Cardiovascular</subject><subject>CoreValve Revalving System</subject><subject>failed surgical aortic bioprosthesis</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Heart Valve Prosthesis</subject><subject>Heart Valve Prosthesis Implantation - adverse effects</subject><subject>Heart Valve Prosthesis Implantation - instrumentation</subject><subject>Heart Valve Prosthesis Implantation - methods</subject><subject>Heart Valve Prosthesis Implantation - mortality</subject><subject>Humans</subject><subject>Italy</subject><subject>Male</subject><subject>Prosthesis Design</subject><subject>Prosthesis Failure</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>TAVI</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1936-8798</issn><issn>1876-7605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhi0EoqXwAhyQb5yyjJ3EiSWE1K4oVKqExLZcLceeFIfEXuxkpX17HLZw4MBpRuP_n_F8Q8hrBhsGTLwbNoNxfsOBsVzYAPAn5Jy1jSgaAfXTnMtSFG0j2zPyIqUBQIBs-HNyxjljtRDVOUl3Uftk9PwdZ4z0mx4PWDhf_E7ozbQftZ_17IKn98n5B7oNEU-PX_GQ41rbHdOME-1DpNfajWjpbokPzuiRXoY4O0OvXNjHkPKUhOkledbrMeGrx3hB7q8_3m0_F7dfPt1sL28LU5U1LyrDepTIUdaya5iQokOQZcf7StsWas2s6TrJqhYM1IYJbrWAVnIrtah6W16Qt6e-efTPBdOsJpcMjnklDEtSEgSrq7qsspKflCZ_MkXs1T66ScejYqBW1mpQK2u1sl5rmXU2vXlsv3QT2r-WP3Cz4P1JgHnJg8OoknHoDVoX0czKBvf__h_-sZvR-ZXqDzxiGsISfcanmEpcgdqt116PzRhAw7ksfwE-L6ZR</recordid><startdate>201111</startdate><enddate>201111</enddate><creator>Bedogni, Francesco, MD</creator><creator>Laudisa, Maria Luisa, MD, PhD</creator><creator>Pizzocri, Samuele, MD</creator><creator>Tamburino, Corrado, MD</creator><creator>Ussia, Gian Paolo, MD</creator><creator>Petronio, Anna Sonia, MD</creator><creator>Napodano, Massimo, MD</creator><creator>Ramondo, Angelo, MD</creator><creator>Presbitero, Patrizia, MD</creator><creator>Ettori, Federica, MD</creator><creator>Santoro, Gennaro, MD</creator><creator>Klugman, Silvio, MD</creator><creator>De Marco, Federico, MD</creator><creator>Brambilla, Nedy, MD</creator><creator>Testa, Luca, MD, PhD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201111</creationdate><title>Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses</title><author>Bedogni, Francesco, MD ; Laudisa, Maria Luisa, MD, PhD ; Pizzocri, Samuele, MD ; Tamburino, Corrado, MD ; Ussia, Gian Paolo, MD ; Petronio, Anna Sonia, MD ; Napodano, Massimo, MD ; Ramondo, Angelo, MD ; Presbitero, Patrizia, MD ; Ettori, Federica, MD ; Santoro, Gennaro, MD ; Klugman, Silvio, MD ; De Marco, Federico, MD ; Brambilla, Nedy, MD ; Testa, Luca, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4352-4c1fe9e2e959b71696be093b2f4ad805a1dcbb91480c05c162da60892d9a64fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aortic Valve Stenosis - diagnosis</topic><topic>Aortic Valve Stenosis - physiopathology</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Bioprosthesis</topic><topic>Cardiac Catheterization - adverse effects</topic><topic>Cardiac Catheterization - instrumentation</topic><topic>Cardiac Catheterization - mortality</topic><topic>Cardiovascular</topic><topic>CoreValve Revalving System</topic><topic>failed surgical aortic bioprosthesis</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Heart Valve Prosthesis</topic><topic>Heart Valve Prosthesis Implantation - adverse effects</topic><topic>Heart Valve Prosthesis Implantation - instrumentation</topic><topic>Heart Valve Prosthesis Implantation - methods</topic><topic>Heart Valve Prosthesis Implantation - mortality</topic><topic>Humans</topic><topic>Italy</topic><topic>Male</topic><topic>Prosthesis Design</topic><topic>Prosthesis Failure</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>TAVI</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bedogni, Francesco, MD</creatorcontrib><creatorcontrib>Laudisa, Maria Luisa, MD, PhD</creatorcontrib><creatorcontrib>Pizzocri, Samuele, MD</creatorcontrib><creatorcontrib>Tamburino, Corrado, MD</creatorcontrib><creatorcontrib>Ussia, Gian Paolo, MD</creatorcontrib><creatorcontrib>Petronio, Anna Sonia, MD</creatorcontrib><creatorcontrib>Napodano, Massimo, MD</creatorcontrib><creatorcontrib>Ramondo, Angelo, MD</creatorcontrib><creatorcontrib>Presbitero, Patrizia, MD</creatorcontrib><creatorcontrib>Ettori, Federica, MD</creatorcontrib><creatorcontrib>Santoro, Gennaro, MD</creatorcontrib><creatorcontrib>Klugman, Silvio, MD</creatorcontrib><creatorcontrib>De Marco, Federico, MD</creatorcontrib><creatorcontrib>Brambilla, Nedy, MD</creatorcontrib><creatorcontrib>Testa, Luca, MD, PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JACC. Cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bedogni, Francesco, MD</au><au>Laudisa, Maria Luisa, MD, PhD</au><au>Pizzocri, Samuele, MD</au><au>Tamburino, Corrado, MD</au><au>Ussia, Gian Paolo, MD</au><au>Petronio, Anna Sonia, MD</au><au>Napodano, Massimo, MD</au><au>Ramondo, Angelo, MD</au><au>Presbitero, Patrizia, MD</au><au>Ettori, Federica, MD</au><au>Santoro, Gennaro, MD</au><au>Klugman, Silvio, MD</au><au>De Marco, Federico, MD</au><au>Brambilla, Nedy, MD</au><au>Testa, Luca, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses</atitle><jtitle>JACC. Cardiovascular interventions</jtitle><addtitle>JACC Cardiovasc Interv</addtitle><date>2011-11</date><risdate>2011</risdate><volume>4</volume><issue>11</issue><spage>1228</spage><epage>1234</epage><pages>1228-1234</pages><issn>1936-8798</issn><eissn>1876-7605</eissn><abstract>Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses Francesco Bedogni, Maria Luisa Laudisa, Samuele Pizzocri, Corrado Tamburino, Gian Paolo Ussia, Anna Sonia Petronio, Massimo Napodano, Angelo Ramondo, Patrizia Presbitero, Federica Ettori, Gennaro Santoro, Silvio Klugman, Federico De Marco, Nedy Brambilla, Luca Testa CoreValve Revalving System (Medtronic, Minneapolis, Minnesota) implantation could be a valid option for patients with a failed aortic bioprosthesis deemed at prohibitive risk for surgical redo. In this multicenter consecutive cohort of 25 patients, the CoreValve Revalving System was feasible and effective regardless of the prevalent cause of failure (regurgitation or stenosis), with excellent procedural success and a considerable 6-month survival rate. These results can significantly affect the treatment of such a high-risk population.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22115664</pmid><doi>10.1016/j.jcin.2011.10.002</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1936-8798
ispartof JACC. Cardiovascular interventions, 2011-11, Vol.4 (11), p.1228-1234
issn 1936-8798
1876-7605
language eng
recordid cdi_proquest_miscellaneous_906154534
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aged
Aged, 80 and over
Aortic Valve Stenosis - diagnosis
Aortic Valve Stenosis - physiopathology
Aortic Valve Stenosis - surgery
Bioprosthesis
Cardiac Catheterization - adverse effects
Cardiac Catheterization - instrumentation
Cardiac Catheterization - mortality
Cardiovascular
CoreValve Revalving System
failed surgical aortic bioprosthesis
Feasibility Studies
Female
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation - adverse effects
Heart Valve Prosthesis Implantation - instrumentation
Heart Valve Prosthesis Implantation - methods
Heart Valve Prosthesis Implantation - mortality
Humans
Italy
Male
Prosthesis Design
Prosthesis Failure
Risk Assessment
Risk Factors
Severity of Illness Index
TAVI
Time Factors
Treatment Outcome
title Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A16%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcatheter%20Valve-in-Valve%20Implantation%20Using%20CoreValve%20Revalving%20System%20for%20Failed%20Surgical%20Aortic%20Bioprostheses&rft.jtitle=JACC.%20Cardiovascular%20interventions&rft.au=Bedogni,%20Francesco,%20MD&rft.date=2011-11&rft.volume=4&rft.issue=11&rft.spage=1228&rft.epage=1234&rft.pages=1228-1234&rft.issn=1936-8798&rft.eissn=1876-7605&rft_id=info:doi/10.1016/j.jcin.2011.10.002&rft_dat=%3Cproquest_cross%3E906154534%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=906154534&rft_id=info:pmid/22115664&rft_els_id=S1936879811007229&rfr_iscdi=true